Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) went up by 31.95% from its latest closing price compared to the recent 1-year high of $31.24. The company’s stock price has collected 0.99% of gains in the last five trading sessions. Press Release reported on 09/28/21 that Lipocine Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO(R)
Is It Worth Investing in Clarus Therapeutics Holdings Inc. (NASDAQ :CRXT) Right Now?
Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) scored a price-to-earnings ratio above its average ratio, recording 8.91 x from its present earnings ratio. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Clarus Therapeutics Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $14.25. Today, the average trading volume of CRXT was 1.02M shares.
CRXT’s Market Performance
CRXT stocks went up by 0.99% for the week, with a monthly drop of -46.05% and a quarterly performance of -59.33%. The volatility ratio for the week stands at 12.31% while the volatility levels for the past 30 days are set at 14.26% for Clarus Therapeutics Holdings Inc.. The simple moving average for the period of the last 20 days is -3.24% for CRXT stocks with a simple moving average of -42.25% for the last 200 days.
CRXT Trading at -30.34% from the 50-Day Moving Average
After a stumble in the market that brought CRXT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.68% of loss for the given period.
Volatility was left at 14.26%, however, over the last 30 days, the volatility rate increased by 12.31%, as shares sank -36.91% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -53.99% lower at present.
During the last 5 trading sessions, CRXT rose by +23.03%, in comparison to the 20-day moving average, which settled at $5.45. In addition, Clarus Therapeutics Holdings Inc. saw -59.72% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CRXT
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.96.